Investigating how pollen from donor grass species can facilitate lateral gene transfer (LGT) into recipient species. This research tests whether heterospecific pollen tube growth on grass stigmas enables DNA incorporation into embryos, with implications for understanding gene flow in major crops.
This research investigates the mechanism behind lateral gene transfer (LGT) in grasses, specifically testing whether illegitimate pollination—the growth of pollen tubes from one species on the stigma of another—provides a route for DNA to move between grass species. The work addresses a fundamental gap in understanding how genes cross species boundaries in grasses, a phenomenon that has been demonstrated through comparative genomics but whose biological mechanism remains unclear. The findings have implications for crop genetics, evolutionary biology, and our understanding of gene flow in wind-pollinated species, including major agricultural crops.
Research approach:
Key scientific premise:
This is an active fundamental research program at the hypothesis-testing stage. The underlying observation that LGT occurs among grasses is well-established through prior comparative genomics work recognized by the 2021 IAPT Stebbins Medal. Prior laboratory crosses have demonstrated that heterospecific pollen tubes can grow and produce partial hybrids in controlled conditions. The current validation phase involves systematic experimental testing of specific predictions about pollen tube growth rates and DNA incorporation frequencies. The research is positioned to generate mechanistic insights into LGT rather than deliver an immediately deployable technology or product.
The University of Sheffield is a large, comprehensive public research university with a global footprint and a strong applied ethos. Industry engages through an advanced manufacturing campus with open-access pilot lines, metrology suites, digital factory demonstrators, and qualification-grade testbeds co-located with OEMs and suppliers. The medical school’s integration with regional NHS trusts enables clinical trials, device evaluation, and real‑world data studies. Research is funded by UKRI councils and Innovate UK, with additional support from the National Institute for Health and Care Research and industry co‑funding. A dedicated commercialization office manages IP, licensing, spinouts, and streamlined agreements for sponsored work and facility access.